Feb 27, 2026 06:00AM
Feb 25, 2026 04:07PM
Nov 5, 2025 04:06PM
Oct 1, 2025 08:03AM
Oct 1, 2025 08:03AM
Aug 4, 2025 08:03AM
Aug 4, 2025 08:03AM Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
Jun 2, 2025 08:08AM
Jun 2, 2025 08:03AM
Feb 26, 2025 04:13PM
Nov 6, 2024 04:12PM
May 8, 2024 04:16PM
Mar 7, 2024 09:33AM
Feb 28, 2024 06:03PM Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 9, 2024 04:05PM
Jan 5, 2024 08:02AM
Jan 5, 2024 08:02AM
Jan 4, 2024 04:50PM
Jan 4, 2024 04:49PM
Nov 8, 2023 04:11PM
Oct 16, 2023 08:03AM Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida
Aug 9, 2023 04:17PM
Jul 19, 2023 06:00AM
Jul 19, 2023 06:00AM
Jul 19, 2023 01:00AM
Jun 20, 2023 11:45AM
Jun 1, 2023 08:05AM
Jun 1, 2023 08:03AM Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
May 10, 2023 04:27PM
Mar 15, 2023 04:11PM
Mar 15, 2023 04:11PM
Feb 7, 2023 08:20AM
Feb 7, 2023 08:03AM
Feb 7, 2023 08:03AM
Jan 25, 2023 08:03AM Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
Jan 25, 2023 08:03AM
Dec 19, 2022 04:10PM
Dec 19, 2022 04:10PM
Dec 19, 2022 04:10PM
Nov 9, 2022 04:11PM
Nov 9, 2022 04:11PM
Aug 9, 2022 04:25PM Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update
Aug 9, 2022 04:25PM
May 10, 2022 04:11PM
May 10, 2022 04:11PM
Mar 16, 2022 04:20PM
Mar 16, 2022 04:20PM
Feb 7, 2022 08:03AM
Feb 7, 2022 08:03AM Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2021 Total Revenues; Provides 2022 Total Revenue Guidance and Corporate Update
Feb 7, 2022 08:03AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All